… To date, no drug or vaccine has been approved to treat the severe disease caused …
coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets …

The current Coronavirus disease 2019 or COVID-19 … by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-… cycle, we asked whether drugs targeting lipid metabolism, such as …

… Accordingly, numerous drug targets are identified by … This review summarizes the promising
drug targets for COVID-19… for repurposing the available clinical drugs. In addition, it gives a …

… target the stages in the virus life cycle. In this review, the potential drug targets for drug …
and an overview of the current status of drug development against SARS-CoV-2 infection is …

… COVID-19 from binding, and consequently cellular entry and injury. Comparatively, soluble
ACE2, which has a higher affinity to COVID-19, can neutralize COVID-19 … of COVID-19 may …

… This review also summarizes plant-based medicines for the treatment of COVID-19 such as
… targets being repurposed against COVID-19 and viral elements that are used in COVID-19 …

… at risk of progression of COVID-19 and their molecular … to identify biomarkers and drug targets
that we review here. … for biomarker identification and drug repurposing. The selected topics …

… spread of novel coronavirus pneumonia (COVID-19) has led … and relies on the identification
of drug-target (DT) interactions … DT binding affinities for heterogeneous drugs. We propose a …

… -19, including antiviral drugs and host-targeting therapies (figure 1). A detailed discussion
of repurposed drugs for COVID-19 can be found in a review by Sanders and colleagues. …

… drugs for the treatment of COVID-19. Furthermore, considering the clinical use of several
NLRP3 inhibitor drugs for … potential usefulness of these agents in the treatment of COVID-19. …